| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 7.77e-06 | 103 | 25 | 4 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 2.92e-05 | 144 | 25 | 4 | GO:0016798 | |
| Domain | Glycoside_hydrolase_SF | 1.92e-03 | 53 | 23 | 2 | IPR017853 | |
| Domain | TSP_1 | 2.71e-03 | 63 | 23 | 2 | PF00090 | |
| Domain | TSP1_rpt | 2.88e-03 | 65 | 23 | 2 | IPR000884 | |
| Domain | TSP1 | 2.88e-03 | 65 | 23 | 2 | PS50092 | |
| Domain | TSP1 | 2.88e-03 | 65 | 23 | 2 | SM00209 | |
| Domain | LRR_8 | 1.86e-02 | 171 | 23 | 2 | PF13855 | |
| Domain | Leu-rich_rpt_typical-subtyp | 1.98e-02 | 177 | 23 | 2 | IPR003591 | |
| Domain | LRR_TYP | 1.98e-02 | 177 | 23 | 2 | SM00369 | |
| Domain | LRR | 2.51e-02 | 201 | 23 | 2 | PS51450 | |
| Pathway | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | 1.01e-04 | 12 | 18 | 2 | M660 | |
| Pathway | REACTOME_HYALURONAN_UPTAKE_AND_DEGRADATION | 1.01e-04 | 12 | 18 | 2 | MM14868 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 2.07e-04 | 17 | 18 | 2 | M666 | |
| Pathway | REACTOME_HYALURONAN_METABOLISM | 2.07e-04 | 17 | 18 | 2 | MM14864 | |
| Pathway | WP_GLYCOSAMINOGLYCAN_DEGRADATION | 2.07e-04 | 17 | 18 | 2 | M39832 | |
| Pathway | KEGG_GLYCOSAMINOGLYCAN_DEGRADATION | 3.19e-04 | 21 | 18 | 2 | M3624 | |
| Pathway | KEGG_PENTOSE_AND_GLUCURONATE_INTERCONVERSIONS | 5.71e-04 | 28 | 18 | 2 | M19580 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.11e-03 | 39 | 18 | 2 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.11e-03 | 39 | 18 | 2 | MM15165 | |
| Pathway | KEGG_PORPHYRIN_AND_CHLOROPHYLL_METABOLISM | 1.23e-03 | 41 | 18 | 2 | M7399 | |
| Pathway | KEGG_DRUG_METABOLISM_OTHER_ENZYMES | 1.89e-03 | 51 | 18 | 2 | M17726 | |
| Pathway | KEGG_STARCH_AND_SUCROSE_METABOLISM | 1.97e-03 | 52 | 18 | 2 | M14171 | |
| Pubmed | Involvement of human UGT2B7 and 2B15 in rofecoxib metabolism. | 1.39e-05 | 8 | 25 | 2 | 12695355 | |
| Pubmed | 3.80e-04 | 40 | 25 | 2 | 31152445 | ||
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.46e-06 | 145 | 26 | 4 | 96712c68ab759d7ade0d912581a1a7c25dc6def8 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 4.49e-05 | 119 | 26 | 3 | 6425425b2e622c97b6c74c530ccbfe394d3b202d | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Pvalb-Pvalb_Vipr2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 7.28e-05 | 140 | 26 | 3 | 72c272f44e5600b3037c1dbf9d3a4669a35588d8 | |
| ToppCell | facs-Large_Intestine-Proximal-3m-Epithelial-Goblet_cell,_top_of_crypt_(Distal)|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.58e-05 | 148 | 26 | 3 | dfd3f2c4b884ea9e23831a242a89ac985b409640 | |
| ToppCell | Mild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass | 1.18e-04 | 165 | 26 | 3 | 93d3909a0f5f43d473d5005c842d7d73e25eceed | |
| ToppCell | Mild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass | 1.18e-04 | 165 | 26 | 3 | 5fa9552c37890c5cc7e672a47038aebba2413cb4 | |
| ToppCell | Endothelial-B-Donor_04|World / lung cells shred on cell class, cell subclass, sample id | 1.23e-04 | 167 | 26 | 3 | 6a03d16165e0b003092c39972928981abd4a75aa | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Pericyte_2|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.29e-04 | 170 | 26 | 3 | 5570c0e825bca77613bf0ebde620cf744fa1cb84 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 173 | 26 | 3 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 1.36e-04 | 173 | 26 | 3 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.38e-04 | 174 | 26 | 3 | 18ab52d8bbca0507fee220e0c4fc765fc47dda34 | |
| ToppCell | Adult-Endothelial-endothelial_cell_of_artery-D175|Adult / Lineage, Cell type, age group and donor | 1.41e-04 | 175 | 26 | 3 | 0a65ddfa8c2e8efb5b5338cf07661cb78157a23c | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 177 | 26 | 3 | a0b172f40e0df97a288a5549ae7066697ad469b3 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-D-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.46e-04 | 177 | 26 | 3 | ab8f09e118e4df696b0b4d33f013da020bdbd351 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 178 | 26 | 3 | 5cc182e6faa7ba5b88378d2c953be29bbbb95a7e | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.48e-04 | 178 | 26 | 3 | f9a16bc3f09c35c7d30e3809da024bc2dcf746ed | |
| ToppCell | 3'-Child09-12-SmallIntestine-Endothelial-blood_vessel_EC-Mature_venous_EC|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.58e-04 | 182 | 26 | 3 | 3cbeaf7904a76c32137a00abb20e302d3d3c8bb8 | |
| ToppCell | 3'-Child04-06-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.79e-04 | 190 | 26 | 3 | ec6b8e2852e1cce0217ff61243defe98b2351640 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 191 | 26 | 3 | c379a499dabf3c9ed80f47adbb2d949821c5b053 | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Vein_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.82e-04 | 191 | 26 | 3 | 9fc674a58f20b47255e4457d5195c8cff17b0414 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 192 | 26 | 3 | 1990dc8a81594018a5bf596be99d0b5f0af0f58f | |
| ToppCell | Control-Endothelial-VE_Arterial|Endothelial / Disease state, Lineage and Cell class | 1.85e-04 | 192 | 26 | 3 | 7e89b9125e8b85f6be85eeccef5c8644647ab0e1 | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 192 | 26 | 3 | c72a082c93a8825adbfef37f889ba3a7052f201b | |
| ToppCell | droplet-Lung-1m-Endothelial-venous_endothelial-vein_endothelial_cell-vein_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.85e-04 | 192 | 26 | 3 | 845cc9c18b4436b07dd3ce7980052683937546d2 | |
| ToppCell | tumor_Lung-Endothelial_cells-Stalk-like_ECs|tumor_Lung / Location, Cell class and cell subclass | 1.88e-04 | 193 | 26 | 3 | 21fec35587ffb5c0157e54a821ce3ffd3e24e536 | |
| ToppCell | 5'-Adult-Appendix-Endothelial-blood_vessel_EC-Mature_venous_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.88e-04 | 193 | 26 | 3 | c0973a2c97deb7176c2f617c8760a55f7edc9839 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic-EC_venous_systemic_L.2.2.0.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-04 | 194 | 26 | 3 | 21854ead32c06c8dbd0e4f26b0dd82fdaadb98a8 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 194 | 26 | 3 | 2e5b195e02dcd5e9432b9a98b22e0478e65b9ba2 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_systemic|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-04 | 194 | 26 | 3 | 87db3a66da47728d1d649a56256517d7e137de5f | |
| ToppCell | (6)_Endothelial-B_(Artery)|World / Lung cell shreds - cell class (v4) and cell subclass (v4) | 1.91e-04 | 194 | 26 | 3 | 0cf4e67d4024652794b5bfdd4a71a7d98900b4c8 | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.91e-04 | 194 | 26 | 3 | a429d22c8c9d0fd3bfa9f877a6364cecad68db30 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-04 | 194 | 26 | 3 | 3446bbe12767fc2006c5d6a39758f31d8f899409 | |
| ToppCell | 356C-Endothelial_cells-Endothelial-A_(Artery)-|356C / Donor, Lineage, Cell class and subclass (all cells) | 1.91e-04 | 194 | 26 | 3 | b6b5b0ab506b05a005ba8a05a3c7f4c725ba9200 | |
| ToppCell | 3'-Broncho-tracheal-Endothelial-Blood_vessel_EC-vein_endothelial_cell|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-04 | 194 | 26 | 3 | ce630a196e1c39b29e49f843ec016b053027d59e | |
| ToppCell | 3'-Broncho-tracheal-Endothelial|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-04 | 194 | 26 | 3 | 8b6d13cfd04f7ff0847ad7cfbbca4e66e07b8344 | |
| ToppCell | IPF-Endothelial-VE_Peribronchial|World / Disease state, Lineage and Cell class | 1.94e-04 | 195 | 26 | 3 | 120296531bbc8080dcabacbd64733cc1dc34603a | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular-VE_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.94e-04 | 195 | 26 | 3 | 517af3e6784f02c382df6f5691945eefaa9ec4ae | |
| ToppCell | 5'-Adult-LargeIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.00e-04 | 197 | 26 | 3 | 61b1b10a017cbeb17f8529fcae66cba77ee2f115 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 197 | 26 | 3 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 197 | 26 | 3 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | 5'-Adult-SmallIntestine-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-04 | 198 | 26 | 3 | 58508a8df2714d769f137794c29441a7bd38b350 | |
| ToppCell | Tracheal-NucSeq-Endothelial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-04 | 198 | 26 | 3 | 77e31b6edeeb5ccd5cd3f080898c96bf9ab9f98d | |
| ToppCell | 5'-Adult-Distal_Rectal-Endothelial-blood_vessel_EC-Mature_arterial_EC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.03e-04 | 198 | 26 | 3 | 8a55589b9244283e4b0b423a4a6d6202e8e0fec9 | |
| ToppCell | Tracheal-NucSeq-Endothelial-Endothelia_vascular|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.03e-04 | 198 | 26 | 3 | f7aa809040fa9f5782b92eec1f289d690eb5c7bd | |
| ToppCell | Tracheal-10x3prime_v2-Endothelial-Endothelia_vascular-VE_systemic_venous|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 199 | 26 | 3 | d359f3e1595ba8d8a3dc9eb2e8f2b61f3247c7a1 | |
| ToppCell | distal-Endothelial-Artery-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.06e-04 | 199 | 26 | 3 | 8acf381087268fcf13f025e3b67e028bf1f9b77e | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.06e-04 | 199 | 26 | 3 | 6fb81388c5045e81c3849a7136bdff3f953f044e | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW10-Neuronal-Intermediate|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 2.06e-04 | 199 | 26 | 3 | cf592d93612023a13de21e0fb8c6b13714f9af71 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | 9f889f7ff0b3ba2750aa757b94680a9f7014fd0d | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel-SVEC|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-04 | 200 | 26 | 3 | 147ceed692655f4ed73b8a57b0b3224def1f3055 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-04 | 200 | 26 | 3 | dc244a5ccec1b793dc4371fb2cd2c3fd4226283e | |
| ToppCell | Parenchymal-10x5prime-Endothelial-Endothelia_vascular-VE_pulmonary_arterial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | ac6b8bc9998d303f788511b8f111e682ea9f3df8 | |
| ToppCell | cellseq2-Endothelial|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-04 | 200 | 26 | 3 | 81bdf7a1ddc3e82b96526449e662cca26d7297b1 | |
| ToppCell | cellseq2-Endothelial-Endothelial_Vascular-Endothelial_large_blood_vessel|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.09e-04 | 200 | 26 | 3 | 0afc7a0f87eac48f772759c3b626758089733361 | |
| ToppCell | Bronchial-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | a3b09580738783c6bff31ea33d5188912e56b8a7 | |
| ToppCell | Tracheal-10x5prime-Endothelial-Endothelia_vascular-VE_systemic_venous|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | 06ffa5baad3e699cf66d8b2c7513649e1d2c7e62 | |
| ToppCell | Tracheal-10x5prime-Endothelial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 2.09e-04 | 200 | 26 | 3 | 71ba0e48ca4ded077f2b96a0cf4f2331f2e25d15 | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW16-Neuronal-Intermediate|GW16 / Sample Type, Dataset, Time_group, and Cell type. | 2.09e-04 | 200 | 26 | 3 | a3fcd901cb281920f1bafdfd676399a6dc37355e | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Trf.Ctps_(Ctps)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.94e-04 | 67 | 26 | 2 | 820120f1f8500c948ef54280e5237f9b311f1b3e | |
| ToppCell | Entopeduncular-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 6.94e-04 | 67 | 26 | 2 | c6a3ac0829f924e0c7822df2ef8f45e7925f2d3d | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(MyelinProcess)-|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.72e-03 | 106 | 26 | 2 | 67e258524e2e5d0f1f21f681857c438f58aa5327 | |
| ToppCell | Entopeduncular-Macroglia-OLIGODENDROCYTE-O2-Trf-Oligodendrocyte.Trf.Ndrg2_(MyelinProcess)|Entopeduncular / BrainAtlas - Mouse McCarroll V32 | 1.72e-03 | 106 | 26 | 2 | 34cd8c6eb32a486ef72d86238d2a229408ea7d1d | |
| ToppCell | Control-CD4+_T_activated|Control / Disease condition and Cell class | 2.06e-03 | 116 | 26 | 2 | e3d1a90a229f5697b2b715574bb96790a435f73b | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 2.13e-03 | 118 | 26 | 2 | f76fc6db7368a1e8e5e4f8535fc3dc78afe13b9b | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-03 | 118 | 26 | 2 | aefad0b35aff980b6a2a98057735442e8a65ab04 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.13e-03 | 118 | 26 | 2 | 0dcac16eea8e7978de370a815da9a0cdd212598e | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 2.13e-03 | 118 | 26 | 2 | 7da3957d102e9f9825fc2609d6d0bd9ca6a3fba4 | |
| ToppCell | PBMC-Control-Lymphocyte-T/NK-CD4+_T-CD4+_T_activated-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09) | 2.13e-03 | 118 | 26 | 2 | c5c6724e0e526d7c2fc8cabff4a112a900ec997f | |
| ToppCell | LPS-IL1RA-Unknown|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.13e-03 | 118 | 26 | 2 | 6cb4063b83f867b782080ce5b1199b51bb277f2a | |
| ToppCell | Control-Lymphoid_T/NK-CD4+_T_activated|Control / Disease group, lineage and cell class | 2.16e-03 | 119 | 26 | 2 | d7352d0dafbb664619b7a1e3cd07b159fdfec197 | |
| ToppCell | facs-Lung-Endomucin-24m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.16e-03 | 119 | 26 | 2 | c3f1223356e7f245a460ea5568a223e34e458dc1 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Nr2f2_Necab1|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.35e-03 | 124 | 26 | 2 | 298ff8bd8f0459f44ce8a8aea889c6f1cf84ac5f | |
| ToppCell | LPS-IL1RA-Unknown-Endothelial-Pericyte_2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.38e-03 | 125 | 26 | 2 | 2938a1d62afe1e0a3abba5eb92f07b886cc0accd | |
| ToppCell | LPS-IL1RA-Epithelial_alveolar-Mes-Like-AT1-AT2|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.50e-03 | 128 | 26 | 2 | 082b3dc312b033c9b21cf73499009a1dc049ee2b | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Mucinous_Adenocarcinoma-6|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.69e-03 | 133 | 26 | 2 | d680c0cf37949aad7bdf04ff5093f005a8c982d6 | |
| ToppCell | Mild/Remission-B_intermediate-14|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 2.73e-03 | 134 | 26 | 2 | 5bd1e3fa6278facd9e949e9e5e244e700190126b | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage_4|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.77e-03 | 135 | 26 | 2 | c4d3c9eba2a85ac40fea5ecfcc2b442a472323d0 | |
| ToppCell | primary_visual_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Chodl|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.85e-03 | 137 | 26 | 2 | 5cb84392e4483f50e09fb7395e2ec98f3eb6ecf3 | |
| ToppCell | TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Embryonal_Carcinoma,_Immature_Teratoma,_Mature_Teratoma,_Yolk_Sac_Tumor|TCGA-Testes / Sample_Type by Project: Shred V9 | 2.89e-03 | 138 | 26 | 2 | f7c40156c34d2d910bbda5ba07540ad0f6f22981 | |
| ToppCell | frontal_cortex-Neuronal-GABAergic_neuron-Sst-Sst_Tac1_Htr1d|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 2.93e-03 | 139 | 26 | 2 | fe1657ef9aeda7c530dc7febcd3dcd0e1d5f8a48 | |
| ToppCell | Mild/Remission-B_intermediate-14|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.02e-03 | 141 | 26 | 2 | 69e32125a0e8f0c8561e5e7a93607f368f09546f | |
| ToppCell | LPS-antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.14e-03 | 144 | 26 | 2 | 1b9e95e4f6e40042d3cf2f94c067f3a6b19428ea | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.19e-03 | 145 | 26 | 2 | 8b13b576fd2e6e33ccb146860a91a53cee0cdd4d | |
| ToppCell | Severe-Myeloid-Mast-|Severe / Condition, Lineage, Cell class and cell subclass | 3.19e-03 | 145 | 26 | 2 | ce307d45425a5191882078f049f85477eec40b69 | |
| ToppCell | Severe-Myeloid-Mast|Severe / Condition, Lineage, Cell class and cell subclass | 3.19e-03 | 145 | 26 | 2 | e0bfd2ffdbd6c197ef0a04e983396ebd87ef7127 | |
| ToppCell | LPS-IL1RA-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-03 | 146 | 26 | 2 | 86cddd0e7f954547b7ffdccb0329cd5c4b725ac1 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-classical_monocyte-classical_monocyte_l2-17-52|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.23e-03 | 146 | 26 | 2 | 26493014daa432db721613ef480d133f3da9eb58 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Myocytic-Pericyte_3|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.23e-03 | 146 | 26 | 2 | 2ac9b487a7991fdc15444aeb93533030e09825bb | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22-Myeloid-Monocytic-Nonclassical_Monocyte-Mono_c4-CD14-CD16|Severe-critical_progression_d12-22 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.36e-03 | 149 | 26 | 2 | c773c2b9685ec44a35246180a93456c8765353f5 | |
| ToppCell | 343B-Lymphocytic-NK_cells-NK_cell_B|NK_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.40e-03 | 150 | 26 | 2 | 98fdc6bdfde84d680e11d8727502b79afbf64303 | |
| ToppCell | Children_(3_yrs)-Immune-mast_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.45e-03 | 151 | 26 | 2 | bbf735c6433c3fc2feedb24ed6f48c51d545fb60 | |
| ToppCell | Children_(3_yrs)-Epithelial-lung_goblet_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.49e-03 | 152 | 26 | 2 | 1b2a39ae159e79f1fb18d6d164bd7acab5299fca | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.54e-03 | 153 | 26 | 2 | 0727dc70e16345645063c586d744bc4ac1710526 | |
| ToppCell | P07-Epithelial-airway_epithelial_cell-ciliated_cell_of_airway|P07 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.54e-03 | 153 | 26 | 2 | 5501095bcf73080872ae01128f21399f9cfc5dd1 | |
| ToppCell | Adult-Immune-mast_cell-D122|Adult / Lineage, Cell type, age group and donor | 3.63e-03 | 155 | 26 | 2 | 7c9de0591d1bf756b8e268b278bbe10bd5415dcd | |
| ToppCell | COVID-19-Mast_cells-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 3.68e-03 | 156 | 26 | 2 | bc10b94673184ef384c6665b16a1209a8975a4f1 | |
| ToppCell | COVID-19-Mast_cells|COVID-19 / group, cell type (main and fine annotations) | 3.68e-03 | 156 | 26 | 2 | 159504d43421ee83b9ab484816333ae549c9c2fd | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-03 | 157 | 26 | 2 | 74038192f016f95f80e0189035ee8ccc22ceb1b8 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|368C / Donor, Lineage, Cell class and subclass (all cells) | 3.72e-03 | 157 | 26 | 2 | 982e6ea78c7dabdb7c07c4a5fb2425d5e45b5b94 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Fibroblasts|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 3.72e-03 | 157 | 26 | 2 | f086753b51860e23f1275bd75e8802d2a7d7b70a | |
| Drug | lorazepam glucuronide | 2.42e-05 | 7 | 25 | 2 | CID000062966 | |
| Drug | potassium selenate | 3.23e-05 | 8 | 25 | 2 | CID000062680 | |
| Drug | Dioxybenzone [131-53-3]; Up 200; 16.4uM; HL60; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 3101_UP | |
| Drug | Aminophylline [317-34-0]; Up 200; 9.6uM; HL60; HT_HG-U133A | 6.20e-05 | 199 | 25 | 4 | 3036_UP | |
| Drug | AC1L9A0M | 7.20e-05 | 74 | 25 | 3 | CID000440822 | |
| Drug | AC1N8H7N | 8.43e-05 | 78 | 25 | 3 | CID004318740 | |
| Drug | T4-G | 1.96e-04 | 19 | 25 | 2 | CID000152424 | |
| Drug | AC1L1OBF | 2.17e-04 | 20 | 25 | 2 | CID000032736 | |
| Drug | estradiol-3-glucuronide | 2.89e-04 | 23 | 25 | 2 | CID000066651 | |
| Drug | L-idaro-1,4-lactone | 4.30e-04 | 28 | 25 | 2 | CID000078997 | |
| Drug | trans-3'-hydroxycotinine | 4.61e-04 | 29 | 25 | 2 | CID000000414 | |
| Drug | 7-hydroxycoumarin glucuronide | 4.61e-04 | 29 | 25 | 2 | CID000125641 | |
| Drug | AC1L9E0Q | 4.94e-04 | 30 | 25 | 2 | CID000443095 | |
| Drug | 4'-HPPH | 5.28e-04 | 31 | 25 | 2 | CID000017732 | |
| Drug | ezetimibe | 5.46e-04 | 147 | 25 | 3 | CID000150311 | |
| Drug | NNAL | 5.63e-04 | 32 | 25 | 2 | CID000104856 | |
| Drug | AC1Q6OQG | 5.99e-04 | 33 | 25 | 2 | CID000009686 | |
| Drug | AC1NOWCJ | 6.74e-04 | 35 | 25 | 2 | CID005120112 | |
| Drug | 3-[(3S,5R,10S,13R,14S,17R)-3-[(2S,4R,5R,6S)-4,5-dihydroxy-6-methyloxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]-2H-furan-5-one | 6.74e-04 | 35 | 25 | 2 | CID010436171 | |
| Drug | AC1LCF1F | 7.12e-04 | 161 | 25 | 3 | CID000627275 | |
| Drug | galangin | 7.53e-04 | 37 | 25 | 2 | CID005281616 | |
| Drug | glucosiduronate | 8.48e-04 | 171 | 25 | 3 | CID000000610 | |
| Drug | testosterone glucuronide | 9.25e-04 | 41 | 25 | 2 | CID000108192 | |
| Drug | sodium cholate | 9.54e-04 | 408 | 25 | 4 | CID000000303 | |
| Drug | tripelennamine | 9.70e-04 | 42 | 25 | 2 | CID000005587 | |
| Drug | ethyl iodoacetate | 9.70e-04 | 42 | 25 | 2 | CID000012183 | |
| Drug | Apigenin [520-36-5]; Down 200; 14.8uM; HL60; HT_HG-U133A | 1.05e-03 | 184 | 25 | 3 | 1321_DN | |
| Disease | Manic Disorder | 1.65e-03 | 71 | 25 | 2 | C0024713 | |
| Disease | Manic | 1.99e-03 | 78 | 25 | 2 | C0338831 | |
| Disease | Depression, Bipolar | 2.04e-03 | 79 | 25 | 2 | C0005587 | |
| Disease | body weight | 3.68e-03 | 1261 | 25 | 5 | EFO_0004338 | |
| Disease | C-X-C motif chemokine 10 measurement | 3.84e-03 | 109 | 25 | 2 | EFO_0008056 | |
| Disease | R-6-hydroxywarfarin measurement | 4.19e-03 | 114 | 25 | 2 | EFO_0803327 | |
| Disease | sleep quality | 4.48e-03 | 118 | 25 | 2 | EFO_0005272 | |
| Disease | asthma (is_marker_for) | 5.09e-03 | 126 | 25 | 2 | DOID:2841 (is_marker_for) | |
| Disease | cataract | 6.33e-03 | 141 | 25 | 2 | MONDO_0005129 | |
| Disease | glaucoma | 7.50e-03 | 154 | 25 | 2 | MONDO_0005041 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| EHLNYWYSLKAYYLA | 456 | Q9H172 | |
| HCDSWYQDSVYYIDT | 66 | Q96RS6 | |
| FYAFYCNNYWRQVYL | 161 | Q6TCH7 | |
| YNYVDAVCYENRLHW | 106 | Q8IWT6 | |
| YLFPDCYNHDYVQNW | 206 | Q12891 | |
| TNTLYWCDAYYDHIE | 706 | Q9NZR2 | |
| YWCNDYKSYSENLCH | 81 | O75951 | |
| AWAAYYAHYYQQQAQ | 536 | Q96AE4 | |
| PWRCDYNIHYLYYWL | 351 | Q8N6Y2 | |
| YNIHYLYYWLKHHYN | 356 | Q8N6Y2 | |
| WYCCAYHFYLQDLNR | 116 | P0DTF9 | |
| ACYLYEQHYRESWEA | 466 | Q13467 | |
| LYYRYGSWTEECQEY | 171 | Q01344 | |
| VDVICLNSYYSWYHD | 496 | P08236 | |
| ALFYRYCYLNWDHYD | 341 | Q5T1A1 | |
| YCYLNWDHYDNIYIT | 346 | Q5T1A1 | |
| YIDLSAWCYYCQAYV | 1176 | Q9UBN7 | |
| AWCYYCQAYVHHQAL | 1181 | Q9UBN7 | |
| YFWNYECDALSAYVA | 1771 | Q3ZCN5 | |
| YCLEYYSWFLKNATY | 491 | C9JL84 | |
| YYRTWNVVVHDWLYY | 416 | P35610 | |
| NVVVHDWLYYYAYKD | 421 | P35610 | |
| NKNCYHYDYNVTDWS | 1216 | Q9UPZ6 | |
| YVYEILVWCVYYNSA | 291 | Q96RI9 | |
| TYAVHNEWYYGLFYC | 91 | P25103 | |
| YQNYSCYKHWQFELL | 211 | O75570 | |
| SDFYFLACWHIYYNN | 356 | Q9NZM6 | |
| SQLQELCWEYYDYSN | 111 | P54855 | |
| EWEQHYSQLYWYYLE | 236 | Q96RS0 | |
| SAYNDVQYQGHYYEW | 136 | P82987 |